EA
ICUI icon

Emerald Advisers’s ICU Medical ICUI Stock Holding History

Emerald Advisers’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,732
Closed -$272K – 254
2023
Q4 		$272K Sell
2,732
-114,884
-98% -$11.2M 0.01% 206
2023
Q3 		$14M Buy
117,616
+1,414
+1% +$211K 0.68% 67
2023
Q2 		$20.7M Buy
116,202
+47,630
+69% +$8.74M 0.91% 51
2023
Q1 		$11.3M Buy
68,572
+68,457
+59,528% +$11.8M 0.54% 81
2022
Q4 		$18.1K Hold
115
– – ﹤0.01% 237
2022
Q3 		$17K Buy
+115
New +$19.1K ﹤0.01% 239

Other funds holding ICUI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Emerald Advisers's ICUI Position: Q1 2024 in Review

Emerald Advisers sold out of ICU Medical (ICUI) in Q1 2024, closing a stake of 2,732 shares — an estimated $272K sold.

Emerald Advisers first reported a position in ICUI in Q3 2022 and held it in 6 quarters. The position peaked at $20.7M in Q2 2023. 252 funds tracked by Wall St. Rank hold ICUI as of Q1 2024.

  • Emerald Advisers reported no remaining ICU Medical position as of Q1 2024 after selling out during the quarter.
  • Emerald Advisers sold 2,732 ICU Medical shares in Q1 2024, an estimated $272K.
  • Emerald Advisers first reported a position in ICU Medical in Q3 2022 and held it in 6 quarters.
  • Emerald Advisers's ICU Medical position peaked at $20.7M in Q2 2023.
  • 252 funds tracked by Wall St. Rank held ICU Medical as of Q1 2024.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.